Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
1 Dec 2018
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
For HSCT in Ph-positive ALL
Against HSCT in Ph-positive ALL
Management of MLL-rearranged ALL
Transplanting adult ALL patients
Large B-cell lymphoma: ZUMA-1 trial
Treating myelodysplastic syndromes
Key advances in ALL and AML
Four studies about relapsed myeloma and advanced disease
Editor's Choice for June 2018
Bladder cancer's relationship with the urinary and gut microbiomes
Celebrating a 10 year partnership: ecancer and the IEO